Wyndham H. Wilson

Also affiliated with National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.424Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.03.494716

Top 44%

0.424DataRank

Top 44%7 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +33 more

Papers

Driven by 38 papers — median percentile 56. Top paper: “Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL”.

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

Cancer Cell(2021)10.1016/j.ccell.2021.10.006

N/A

5.4DataRank · unranked

314 citations

George W. Wright, Da Wei Huang, Brendan P. Hodkinson, Sriram Balasubramanian, Yue Fan +4 more

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of Clinical Oncology(2020)10.1200/jco.20.00303

N/A

5.0DataRank · unranked

152 citations

Kieron Dunleavy, Jeremy S. Abramson, Bayard L. Powell, Brian K. Link, Prapti A. Patel +19 more

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

Blood(2020)10.1182/blood.2019003277

N/A

3.7DataRank · unranked

95 citations

Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang +14 more

Safety and efficacy of navitoclax, a BCL-2 and BCL-X L inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1845332

N/A

2.2DataRank · unranked

94 citations

John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse +4 more

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma

New England Journal of Medicine(2024)10.1056/nejmoa2401532

N/A

1.5DataRank · unranked

68 citations

Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Da Wei Huang, George W. Wright +31 more

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Nature(2000)10.1038/35000501

N/A

1.4DataRank · unranked

9923 citations

Michael B. Eisen, R. Eric Davis, Chi Ma, Izidore S. Lossos, Andreas Rosenwald +32 more

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006397

N/A

1.3DataRank · unranked

44 citations

Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle S. Saba, Liza Lindenberg +11 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

1.1DataRank · unranked

1538 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications

Cancer Cell(2020)10.1016/j.ccell.2020.03.015

N/A

1.1DataRank · unranked

1106 citations

Da Wei Huang, James D. Phelan, Zana Coulibaly, Sandrine Roulland, Ryan M. Young +13 more

Next-Generation Sequencing-Based Monitoring of Circulating Tumor DNA Reveals Clonotypic Heterogeneity in Untreated PTCL

Blood Advances(2021)10.1182/bloodadvances.2020003679

N/A

0.828DataRank · unranked

22 citations

Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Andrea N. Lucas, Allison P. Jacob +5 more

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Blood(2022)10.1182/blood.2022016534

N/A

0.673DataRank · unranked

88 citations

Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder +63 more

BTK drives neutrophil activation for sterilizing antifungal immunity

Journal of Clinical Investigation(2024)10.1172/jci176142

N/A

0.510DataRank · unranked

29 citations

Marissa A. Zarakas, Andrew Wishart, Mark Roschewski, Mariano A. Aufiero, Ágnes Donkó +23 more

Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas

Cancer Cell(2024)10.1016/j.ccell.2024.04.007

N/A

0.505DataRank · unranked

28 citations

Michele Ceribelli, James D. Phelan, Björn Häupl, Da Wei Huang, George W. Wright +19 more

Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1907371

N/A

0.494DataRank · unranked

7 citations

Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy Kimball +8 more

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00029-7

N/A

0.493DataRank · unranked

14 citations

Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y. Song +11 more

A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.03.494716

Top 44%

0.424DataRank

Top 44%7 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +33 more

Phased variants improve DLBCL minimal residual disease detection at the end of therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7565

N/A

0.348DataRank · unranked

3 citations

Jacob J. Chabon, Joanne Soo, Lyron Co Ting Keh, Stefan Alig, André Schultz +15 more

The anti‐CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B‐cell lymphomas

British Journal of Haematology(2025)10.1111/bjh.20219

N/A

0.241DataRank · unranked

4 citations

Christopher Melani, Stefania Pittaluga, Max J. Gordon, James D. Phelan, Jagan Muppidi +7 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Blood Neoplasia(2024)10.1016/j.bneo.2024.100054

N/A

0.165DataRank · unranked

2 citations

Sigrid Dubois, Miloš D. Miljković, Samuel Y. Ng, Bonita R. Bryant, Rahul Lakhotia +8 more

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Hematological Oncology(2023)10.1002/hon.3164_437

N/A

0.104DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, J. D. Phelan, Y. Yang, Theresa Davies‐Hill +17 more

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

Cancer Medicine(2023)10.1002/cam4.5628

N/A

0DataRank · unranked

5 citations

Levi Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl +10 more

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Blood Advances(2023)10.1182/bloodadvances.2023010223

N/A

0DataRank · unranked

0 citations

Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani +10 more

Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma

The Cancer Journal(2020)10.1097/ppo.0000000000000450

N/A

0DataRank · unranked

54 citations

James D. Phelan, Wyndham H. Wilson, Mark Roschewski

Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients

Cancer Cell(2024)10.1016/j.ccell.2024.02.001

N/A

0DataRank · unranked

64 citations

Ekaterina Postovalova, Arina Varlamova, Alexander Bagaev, Maria Sorokina, Olga Kudryashova +36 more

Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2413372121

N/A

0DataRank · unranked

8 citations

Frances A. Tosto, Xiaohu Zhang, Christopher Melani, Mark Roschewski, Erin Beck +13 more

A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies

Maryland Shared Open Access Repository (USMAI Consortium)(2024)10.13016/m2trio-fqf2

N/A

0DataRank · unranked

0 citations

Sigrid Dubois, Miloš Miljkovi?, Samuel Y. Ng, Bonita R Bryant, Rahul Lakhotia +8 more

DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-24-0240

N/A

0DataRank · unranked

4 citations

Carlos A. García‐Prieto, Kostiantyn Dreval, Laura K. Hilton, Jeremy S. Abramson, Nancy L. Bartlett +34 more

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00412

N/A

0DataRank · unranked

2 citations

Xiaohu Zhang, Patricia Alfonso, Patrick J. Morris, Carleen Klumpp‐Thomas, Christopher Melani +12 more

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063

N/A

0DataRank · unranked

61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

Enitociclib ( VIP152 ), venetoclax and prednisone in relapsed or refractory aggressive non‐Hodgkin lymphoma

British Journal of Haematology(2025)10.1111/bjh.70234

N/A

0DataRank · unranked

1 citations

Rahul Lakhotia, Stefania Pittaluga, Svetlana Pack, Anna Marie Juanitez, Ahmed Hamdy +8 more

Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B‐cell lymphoma in the phase III clinical trial of R‐CHOP ± ibrutinib

British Journal of Haematology(2021)10.1111/bjh.17450

N/A

0DataRank · unranked

12 citations

Songbai Wang, Christopher Major, Brendan P. Hodkinson, Michael Schäffer, Laurie H. Sehn +10 more

CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.2002317

N/A

0DataRank · unranked

12 citations

Alba Navarro, Delong Liu, Sarah E. M. Herman, Shih‐Sung Chuang, Irma Slavutsky +9 more

Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.22.445261

N/A

0DataRank · unranked

3 citations

Jie Gao, Shannon Healy, Christopher Rushton, Nicole Thomas, Laura K. Hilton +14 more

The Effectiveness of Dual-Staining Immunohistochemistry in the Detection of Mantle Cell Lymphoma in the Bone Marrow

American Journal of Clinical Pathology(2021)10.1093/ajcp/aqab179

N/A

0DataRank · unranked

0 citations

Hao‐Wei Wang, Dávid Ma, Eddie Martin, Wyndham H. Wilson, Raul C. Braylan +1 more

CAR T-Cell Therapy for Large B-Cell Lymphoma — Who, When, and How?

New England Journal of Medicine(2021)10.1056/nejme2118899

N/A

0DataRank · unranked

70 citations

Dan L. Longo, Wyndham H. Wilson, Mark Roschewski

Association of CEP72 rs924607 with vincristine-induced peripheral neuropathy (PN) in patients with diffuse large B-cell lymphoma on CALGB 50303 (Alliance).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e13535

N/A

0DataRank · unranked

0 citations

Nicholas B. Larson, Timothy M. Pierpont, Nancy L. Bartlett, Andrew D. Zelenetz, Wyndham H. Wilson +5 more

Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-20-0009

N/A

0DataRank · unranked

48 citations

Alina Nicolae, George W. Wright, Christopher Melani, Mark Roschewski, Seth M. Steinberg +5 more

Malignancy in STAT3 Deficient Hyper IgE Syndrome

Journal of Clinical Immunology(2022)10.1007/s10875-021-01197-y

N/A

0DataRank · unranked

8 citations

Christopher Melani, Mark Roschewski, Wyndham H. Wilson, Stefania Pittaluga, Haig Tcheurekdjian +4 more

Wyndham H. Wilson

Indexed papers

Top data-sharing exemplar

Papers